Cutaneous lupus erythematosus: update of therapeutic options part II.

[1]  T. Luger,et al.  Efficacy of tacrolimus 0.1% ointment in cutaneous lupus erythematosus: a multicenter, randomized, double-blind, vehicle-controlled trial. , 2011, Journal of the American Academy of Dermatology.

[2]  J. E. Santo,et al.  Intravenous Immunoglobulin in Lupus Panniculitis , 2010, Clinical reviews in allergy & immunology.

[3]  E. Major.  Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. , 2010, Annual review of medicine.

[4]  V. Madan,et al.  Efficacy of topical tacrolimus 0.3% in clobetasol propionate 0.05% ointment in therapy‐resistant cutaneous lupus erythematosus: a cohort study , 2010, Clinical and experimental dermatology.

[5]  G. Jemec,et al.  A randomized controlled trial of R‐salbutamol for topical treatment of discoid lupus erythematosus , 2009, The British journal of dermatology.

[6]  M. Davis,et al.  Lupus-like syndrome attributable to anti-tumor necrosis factor alpha therapy in 14 patients during an 8-year period at Mayo Clinic. , 2009, Mayo Clinic proceedings.

[7]  J. Callejas-Rubio,et al.  Efalizumab for subacute cutaneous lupus: report of two different outcomes , 2009, Lupus.

[8]  J. Saurat,et al.  Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon‐γ release assay vs. tuberculin skin test , 2009, The British journal of dermatology.

[9]  D. Lipsker,et al.  Extracorporeal photopheresis in recalcitrant lupus erythematosus , 2009, Clinical and experimental dermatology.

[10]  L. French,et al.  Extracorporeal photopheresis: past, present, and future. , 2009, Journal of the American Academy of Dermatology.

[11]  J. Wolf,et al.  MYELOMA-ASSOCIATED POLYNEUROPATHY RESPONDING TO LENALIDOMIDE , 2009, Neurology.

[12]  D. Lipsker,et al.  Association of cigarette smoking but not alcohol consumption with cutaneous lupus erythematosus. , 2009, Archives of dermatology.

[13]  H. Prince,et al.  Refractory subacute cutaneous lupus erythematosus successfully treated with rituximab , 2009, The Australasian journal of dermatology.

[14]  V. Werth,et al.  Analysis of Compact Fluorescent Lights for Use by Patients with Photosensitive Conditions , 2009, Photochemistry and photobiology.

[15]  R. Loddenkemper,et al.  Empfehlungen für das Tuberkulose-Screening vor Gabe von TNF-α-Inhibitoren bei rheumatischen Erkrankungen , 2009, Zeitschrift für Rheumatologie.

[16]  P. C. van de Kerkhof,et al.  Efficacy and safety of pulsed dye laser treatment for cutaneous discoid lupus erythematosus. , 2009, Journal of the American Academy of Dermatology.

[17]  G. Appel,et al.  An update on the use of mycophenolate mofetil in lupus nephritis and other primary glomerular diseases , 2009, Nature Clinical Practice Nephrology.

[18]  T. Gambichler,et al.  Lupus erythematosus tumidus: response to antimalarial treatment in 36 patients with emphasis on smoking. , 2009, Archives of dermatology.

[19]  V. Werth,et al.  Cross-sectional analysis of a collaborative Web-based database for lupus erythematosus-associated skin lesions: prospective enrollment of 114 patients. , 2009, Archives of dermatology.

[20]  V. Werth,et al.  Lenalidomide for the treatment of resistant discoid lupus erythematosus. , 2009, Archives of dermatology.

[21]  V. Werth,et al.  The risk of ultraviolet radiation exposure from indoor lamps in lupus erythematosus. , 2009, Autoimmunity reviews.

[22]  M. García-Carrasco,et al.  Use of rituximab in patients with systemic lupus erythematosus: an update. , 2009, Autoimmunity reviews.

[23]  M. Namazi.  The potential negative impact of proton pump inhibitors on the immunopharmacologic effects of chloroquine and hydroxychloroquine , 2009, Lupus.

[24]  P. O'kelly,et al.  Photoprotective behaviour and sunscreen use: impact on vitamin D levels in cutaneous lupus erythematosus , 2008, Photodermatology, photoimmunology & photomedicine.

[25]  O. FitzGerald,et al.  Hydroxychloroquine‐associated, photo‐induced toxic epidermal necrolysis , 2008, Clinical and experimental dermatology.

[26]  C. Hexsel,et al.  Current sunscreen issues: 2007 Food and Drug Administration sunscreen labelling recommendations and combination sunscreen/insect repellent products. , 2008, Journal of the American Academy of Dermatology.

[27]  Sina Aboutalebi,et al.  Development of systemic lupus erythematosus in a patient with rheumatoid arthritis following treatment conversion of infliximab to adalimumab. , 2008, Journal of drugs in dermatology : JDD.

[28]  J. M. Martín,et al.  Adalimumab-induced lupus erythematosus , 2008, Lupus.

[29]  B. Zimmermann,et al.  Drug-Induced Lupus due to Anti-Tumor Necrosis Factor α Agents , 2008 .

[30]  M. Dimopoulos,et al.  Treatment of plasma cell dyscrasias with lenalidomide , 2008, Leukemia.

[31]  T. Bieber,et al.  Successful treatment of recalcitrant malar rash in a patient with cutaneous lupus erythematosus with efalizumab , 2008, Clinical and experimental dermatology.

[32]  M. Ludgate,et al.  Bullous systemic lupus erythematosus responding to dapsone , 2008, The Australasian journal of dermatology.

[33]  H. Williams,et al.  Evidence-Based Dermatology , 2008, American journal of clinical dermatology.

[34]  M. Khamashta,et al.  Hydroxychloroquine: the cornerstone of lupus therapy , 2008, Lupus.

[35]  N. Del Papa,et al.  Leflunomide-induced subacute cutaneous lupus erythematosus with erythema multiforme-like lesions , 2008, Lupus.

[36]  D. Kouvelas,et al.  Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation , 2008, European Journal of Clinical Pharmacology.

[37]  A. Taher,et al.  Successful Treatment of Refractory Skin Manifestations of Systemic Lupus Erythematosus with Rituximab: Report of a Case , 2008, Dermatology.

[38]  M. Sticherling,et al.  Leflunomide in subacute cutaneous lupus erythematosus – two sides of a coin , 2007, International journal of dermatology.

[39]  Y. Shoenfeld,et al.  Tobacco smoking and autoimmune rheumatic diseases , 2007, Nature Clinical Practice Rheumatology.

[40]  H. Wulf,et al.  Discoid and subacute lupus erythematosus treated with 0.5% R-salbutamol cream. , 2007, Archives of dermatology.

[41]  U. Wollina,et al.  The use of topical calcineurin inhibitors in lupus erythematosus: an overview , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

[42]  R. Gläser,et al.  Resistance to hydroxychloroquine due to smoking in a patient with lupus erythematosus tumidus , 2007, The British journal of dermatology.

[43]  P. Royle,et al.  Dehydroepiandrosterone for systemic lupus erythematosus. , 2007, The Cochrane database of systematic reviews.

[44]  M. Tonelli,et al.  Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[45]  K. Acland,et al.  Adalimumab‐induced cutaneous lupus , 2007, Clinical and experimental dermatology.

[46]  C. Bangert,et al.  Methotrexate in dermatology , 2007, Dermatologic therapy.

[47]  F. Kerdel,et al.  The use of i.v. IG therapy in dermatology , 2007, Dermatologic therapy.

[48]  V. Madan,et al.  Systemic ciclosporin and tacrolimus in dermatology , 2007, Dermatologic therapy.

[49]  S. Kalia,et al.  New concepts in antimalarial use and mode of action in dermatology , 2007, Dermatologic therapy.

[50]  J. Callen,et al.  Azathioprine: a guide for the management of dermatology patients , 2007, Dermatologic therapy.

[51]  J. Jackson.  TNF- alpha inhibitors. , 2007, Dermatologic therapy.

[52]  M. Khamashta,et al.  Autoimmune Diseases Induced by TNF-Targeted Therapies: Analysis of 233 Cases , 2007, Medicine.

[53]  M. Goodfield,et al.  Efalizumab in the treatment of discoid lupus erythematosus. , 2007, Archives of dermatology.

[54]  E. Bröcker,et al.  Sun‐Induced Life‐Threatening Lupus Nephritis , 2007, Annals of the New York Academy of Sciences.

[55]  T. Gambichler,et al.  Mycophenolate sodium for subacute cutaneous lupus erythematosus resistant to standard therapy , 2007, The British journal of dermatology.

[56]  A. Spillane,et al.  Drug-induced lupus erythematosus in a patient treated with adalumimab. , 2007, Journal of the American Academy of Dermatology.

[57]  G. Hughes,et al.  Intravenous immunoglobulin in the treatment of resistant subacute cutaneous lupus erythematosus: a possible alternative , 2007, Clinical Rheumatology.

[58]  H. Wulf,et al.  The relation between sun protection factor and amount of suncreen applied in vivo , 2007, The British journal of dermatology.

[59]  R. Sontheimer.  Desensitization to hydroxychloroquine: alternative interpretations. , 2007, The Journal of rheumatology.

[60]  J. Rodríguez-Peralto,et al.  Lupus‐like reaction to interferon at the injection site: report of five cases , 2007, Journal of cutaneous pathology.

[61]  Lars Alfredsson,et al.  Smoking as a trigger for inflammatory rheumatic diseases , 2007, Current opinion in rheumatology.

[62]  N. Sakakibara,et al.  Successful treatment with topical tacrolimus in four cases of discoid lupus erythematosus , 2006, The Journal of dermatology.

[63]  H. Gollnick,et al.  A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid. , 2006, Archives of dermatology.

[64]  M. Gönül,et al.  A case of hydroxychloroquine induced pruritus. , 2006, European journal of dermatology : EJD.

[65]  Demosthenes Bouros,et al.  Infliximab-induced non-specific interstitial pneumonia and lupus-like eruption. , 2006, European journal of internal medicine.

[66]  T. Bieber,et al.  Methotrexate treatment in cutaneous lupus erythematosus: subcutaneous application is as effective as intravenous administration , 2006, The British journal of dermatology.

[67]  R. Lafyatis,et al.  Antimalarial agents: closing the gate on Toll-like receptors? , 2006, Arthritis and rheumatism.

[68]  M. Gönül,et al.  A case of generalized discoid lupus erythematosus: Successful treatment with Imiquimod cream 5% , 2006, Advances in therapy.

[69]  Akash A. Patel,et al.  Azathioprine in dermatology: the past, the present, and the future. , 2006, Journal of the American Academy of Dermatology.

[70]  C. Kallenberg,et al.  Therapy-resistent lupus skin disease successfully treated with rituximab. , 2006, Rheumatology.

[71]  J. Piette,et al.  Cardiomyopathy Related to Antimalarial Therapy with Illustrative Case Report , 2006, Cardiology.

[72]  M. Heffernan,et al.  Efalizumab-induced subacute cutaneous lupus erythematosus. , 2006, Journal of the American Academy of Dermatology.

[73]  S. Ogden,et al.  Treatment of refractory subacute cutaneous lupus erythematosus with efalizumab. , 2006, Journal of the American Academy of Dermatology.

[74]  I. Rosner,et al.  The Reduction of Serum B‐Lymphocyte Activating Factor levels following Quinacrine Add‐On Therapy in Systemic Lupus Erythematosus , 2006, Scandinavian journal of immunology.

[75]  G. Nesher,et al.  Desensitization to hydroxychloroquine--experience of 4 patients. , 2006, The Journal of rheumatology.

[76]  V. Sigurdsson,et al.  UV hardening therapy: a novel intervention in patients with photosensitive cutaneous lupus erythematosus. , 2006, Journal of the American Academy of Dermatology.

[77]  K. Pizinger,et al.  Coexisting subacute and systemic lupus erythematosus after terbinafine administration: successful treatment with mycophenolate mofetil , 2006, International journal of dermatology.

[78]  H. Shimizu,et al.  Lupus erythematosus profundus successfully treated with dapsone: review of the literature. , 2006, Archives of dermatology.

[79]  R. Norman,et al.  Case reports of etanercept in inflammatory dermatoses. , 2006, Journal of the American Academy of Dermatology.

[80]  J. Callen.  Cutaneous lupus erythematosus: A personal approach to management , 2006, The Australasian journal of dermatology.

[81]  V. Werth,et al.  Therapy of cutaneous lupus erythematosus , 2006 .

[82]  A. Sinha,et al.  Cutaneous lupus erythematosus: Understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies , 2006, Autoimmunity.

[83]  M. Salazar-Páramo,et al.  Pimecrolimus 1% cream for the treatment of discoid lupus erythematosus. , 2005, Rheumatology.

[84]  T. Gambichler,et al.  Intravenous immunoglobulin for recalcitrant subacute cutaneous lupus erythematosus. , 2005, Acta dermato-venereologica.

[85]  M. Marmor.  The dilemma of hydroxychloroquine screening: new information from the multifocal ERG. , 2005, American journal of ophthalmology.

[86]  N. Burrows,et al.  Subacute cutaneous lupus erythematosus precipitated by leflunomide , 2005, Clinical and experimental dermatology.

[87]  T. Lai,et al.  Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy. , 2005, American journal of ophthalmology.

[88]  R. Eisenberg.  Update on rituximab , 2005, Annals of the rheumatic diseases.

[89]  S. Luo,et al.  Successful preventive treatment of congenital heart block during pregnancy in a woman with systemic lupus erythematosus and anti-Sjögren's syndrome A/Ro antibody. , 2005, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[90]  M. Vilar,et al.  Double-blind, randomized, controlled clinical trial of clofazimine compared with chloroquine in patients with systemic lupus erythematosus. , 2005, Arthritis and rheumatism.

[91]  K. David-Bajar,et al.  Subacute cutaneous lupus erythematosus associated with leflunomide. , 2005, Cutis.

[92]  J. Martínez,et al.  Antimalarial myopathy: an underdiagnosed complication? Prospective longitudinal study of 119 patients , 2005, Annals of the rheumatic diseases.

[93]  S. Tyring,et al.  Thalidomide: dermatological indications, mechanisms of action and side‐effects , 2005, The British journal of dermatology.

[94]  H. Miot,et al.  Association between Discoid Lupus erythematosus and Cigarette Smoking , 2005, Dermatology.

[95]  T. Bieber,et al.  Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients , 2005, The British journal of dermatology.

[96]  V. D’Agati,et al.  Development of glomerulonephritis during anti-TNF-α therapy for rheumatoid arthritis , 2005 .

[97]  J. Berthelot,et al.  Leflunomide-induced subacute cutaneous lupus erythematosus. , 2005, Rheumatology.

[98]  M. Rijhwani,et al.  Hypertrophic Lupus Erythematosus Treated Successfully with Acitretin as Monotherapy , 2005, The Journal of dermatology.

[99]  T. R. Schmal,et al.  Long-term thalidomide use in refractory cutaneous lesions of lupus erythematosus: a 65 series of Brazilian patients , 2005, Lupus.

[100]  G. Obermoser,et al.  Skin manifestations of systemic lupus erythematosus refractory to multiple treatment modalities: poor results with mycophenolate mofetil. , 2005, Clinical and experimental rheumatology.

[101]  S. Meller,et al.  Socioeconomic factors in lupus erythematosus. , 2005, Autoimmunity reviews.

[102]  W. High,et al.  Cutaneous lupus erythematosus induced by infliximab. , 2005, Journal of the American Academy of Dermatology.

[103]  T. Schaeverbeke,et al.  Infliximab induced chilblain lupus in a patient with rheumatoid arthritis. , 2005, The Journal of rheumatology.

[104]  H. Ueki.  Koebner phenomenon in lupus erythematosus with special consideration of clinical findings. , 2005, Autoimmunity reviews.

[105]  D. Durand,et al.  Aggravation d’un lupus érythémateux subaigu sous infliximab , 2005 .

[106]  Y. Karim,et al.  Mycophenolate Mofetil and Systemic Lupus Erythematosus: An Overview , 2005 .

[107]  G. Hughes,et al.  Thalidomide for the treatment of resistant cutaneous lupus: efficacy and safety of different therapeutic regimens. , 2005, The American journal of medicine.

[108]  V. Werth,et al.  Rhabdomyolysis associated with quinacrine therapy in a patient with chronic cutaneous lupus erythematosus. , 2005, Journal of drugs in dermatology : JDD.

[109]  D. Lipsker,et al.  The combination of complement deficiency and cigarette smoking as risk factor for cutaneous lupus erythematosus in men; a focus on combined C2/C4 deficiency , 2005, The British journal of dermatology.

[110]  J. Piette,et al.  Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature. , 2005, Autoimmunity reviews.

[111]  Jean Kanitakis,et al.  Lupus erythematosus with leflunomide: induction or reactivation? , 2004, Annals of the rheumatic diseases.

[112]  B. Diffey,et al.  Implication for photosensitive patients of ultraviolet A exposure in vehicles , 2004, The British journal of dermatology.

[113]  M. Aringer,et al.  Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study. , 2004, Arthritis and rheumatism.

[114]  G. Plewig,et al.  Use of sunscreens to protect against ultraviolet-induced lupus erythematosus. , 2004, Arthritis and rheumatism.

[115]  T. Gambichler,et al.  Pimecrolimus 1% cream for cutaneous lupus erythematosus. , 2004, Journal of the American Academy of Dermatology.

[116]  C. Lam,et al.  Double-blind, randomized, placebo-controlled pilot study of leflunomide in systemic lupus erythematosus , 2004, Lupus.

[117]  A. Gaspari,et al.  Photoprotection by thalidomide in patients with chronic cutaneous and systemic lupus erythematosus: discordant effects on minimal erythema dose and sunburn cell formation , 2004, The British journal of dermatology.

[118]  M. Ermani,et al.  Thalidomide neurotoxicity , 2004, Neurology.

[119]  M. Tidman,et al.  Subacute cutaneous lupus erythematosus associated with leflunomide , 2004, Clinical and experimental dermatology.

[120]  C. Antoniou,et al.  Discoid lupus erythematosus‐like eruption induced by infliximab , 2004, Clinical and experimental dermatology.

[121]  F. Ochsendorf.  [Systemic therapy of cutaneous lupus erythematosus]. , 2004, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[122]  T. Luger,et al.  Topical Tacrolimus as a Therapeutic Adjunct in Patients with Cutaneous Lupus erythematosus , 2004, Dermatology.

[123]  K. Davison,et al.  Intravenous immunoglobulin (IVIg) for therapy‐resistant cutaneous lupus erythematosus (LE) , 2004, The Journal of dermatological treatment.

[124]  M. Fitzcharles,et al.  Induction of autoantibodies during prolonged treatment with infliximab. , 2003, Journal of Rheumatology.

[125]  A. Gaspari,et al.  Thalidomide inhibits UVB‐induced mouse keratinocyte apoptosis by both TNF‐α‐dependent and TNF‐α‐independent pathways , 2003 .

[126]  T. Ruzicka,et al.  Topische Behandlung mit Tacrolimus bei Lupus erythematodes tumidus , 2003, Der Hautarzt.

[127]  M. Tarstedt,et al.  Discoid lupus erythematosus treated with cryotherapy , 2003, The Journal of dermatological treatment.

[128]  Lyle L. Moldawer,et al.  Anti-TNF-α therapies: the next generation , 2003, Nature Reviews Drug Discovery.

[129]  T. Tüting,et al.  Systemische Therapie des kutanen Lupus erythematodes , 2003 .

[130]  T. Bieber,et al.  [Systemic treatment of cutaneous lupus erythematosus]. , 2003, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[131]  N. Scheinfeld.  Phenytoin in cutaneous medicine: its uses, mechanisms and side effects. , 2003, Dermatology online journal.

[132]  A S Neubauer,et al.  Detecting chloroquine retinopathy: electro-oculogram versus colour vision , 2003, The British journal of ophthalmology.

[133]  O. Meyer,et al.  Anti-TNF-α-induced systemic lupus syndrome , 2003, Clinical Rheumatology.

[134]  T. Bieber,et al.  Successful Treatment of Chronic Discoid Lupus erythematosus of the Scalp with Imiquimod , 2002, Dermatology.

[135]  T. Luger,et al.  Mycophenolate mofetil and leflunomide: promising compounds for the treatment of skin diseases , 2002, Clinical and experimental dermatology.

[136]  A. Ormerod,et al.  Subacute cutaneous lupus erythematosus associated with phenytoin , 2002, Clinical and experimental dermatology.

[137]  R. Chalmers,et al.  The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus , 2002, The British journal of dermatology.

[138]  M. Richard,et al.  Lupus subaigu multirésistant : traitement par photophérèse , 2002 .

[139]  G. Hughes,et al.  Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents. , 2002, Rheumatology.

[140]  G. Rassner,et al.  Successful treatment of subacute cutaneous lupus erythematosus with mycophenolate mofetil , 2002, The British journal of dermatology.

[141]  J. Sanderson,et al.  Erythrocyte thiopurine methyl transferase assessment prior to azathioprine use in the UK. , 2002, QJM : monthly journal of the Association of Physicians.

[142]  R. Carr,et al.  Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology. , 2002, Ophthalmology.

[143]  B. Fautrel,et al.  Regression of subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis treated with a biologic tumor necrosis factor alpha-blocking agent: comment on the article by Pisetsky and the letter from Aringer et al. , 2002, Arthritis and rheumatism.

[144]  T. Ruzicka,et al.  Methotrexate treatment for refractory subacute cutaneous lupus erythematosus. , 2002, Journal of the American Academy of Dermatology.

[145]  F. Furukawa,et al.  Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis. , 2002, European journal of dermatology : EJD.

[146]  J. Piette,et al.  Transient secondary amenorrhea in women treated by thalidomide. , 2002, European journal of dermatology : EJD.

[147]  B. Stricker,et al.  Etanercept-induced subacute cutaneous lupus erythematosus. , 2001, Rheumatology.

[148]  Joseph Keane,et al.  Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent , 2001 .

[149]  M. Stiller,et al.  Dapsone and sulfones in dermatology: overview and update. , 2001, Journal of the American Academy of Dermatology.

[150]  G. Obermoser,et al.  Discoid lupus erythematosus in a patient receiving cyclosporine for liver transplantation. , 2001, Acta dermato-venereologica.

[151]  T. Ruzicka,et al.  Wiederentdeckung von Thalidomid Erfolgreiche Behandlung des chronisch diskoiden Lupus erythematodes , 2001, Der Hautarzt.

[152]  T. Ruzicka,et al.  Phototesting in lupus erythematosus: a 15-year experience. , 2001, Journal of the American Academy of Dermatology.

[153]  H. Nousari,et al.  Treatment of resistant discoid lupus erythematosus of the palms and soles with mycophenolate mofetil. , 2001, Journal of the American Academy of Dermatology.

[154]  D. Wallace,et al.  Benefyts of lefiunomide in systemic lupus erythematosus: a pilot observational study , 2001, Lupus.

[155]  A. Carmichael,et al.  Fatal toxic epidermal necrolysis associated with hydroxychloroquine , 2001, Clinical and experimental dermatology.

[156]  A. Wells,et al.  Pneumonitis complicating methotrexate therapy for pustular psoriasis , 2001, Journal of the European Academy of Dermatology and Venereology : JEADV.

[157]  M. Coleman.  Dapsone-mediated agranulocytosis: risks, possible mechanisms and prevention. , 2001, Toxicology.

[158]  S. Pérez Santos,et al.  Cutaneous lupus erythematosus. , 2001, Medicina oral : organo oficial de la Sociedad Espanola de Medicina Oral y de la Academia Iberoamericana de Patologia y Medicina Bucal.

[159]  W. Ting,et al.  Local therapy for cutaneous and systemic lupus erythematosus: practical and theoretical considerations , 2001, Lupus.

[160]  S. Cessie,et al.  UVA-1 cold light treatment of SLE: a double blind, placebo controlled crossover trial , 2001, Annals of the rheumatic diseases.

[161]  T. Bieber,et al.  Chilblain lupus erythematosus Hutchinson: successful treatment with mycophenolate mofetil. , 2001, Archives of dermatology.

[162]  H. Zachariae,et al.  The value of amino‐terminal propeptide of type III procollagen in routine screening for methotrexate‐induced liver fibrosis: a 10‐year follow‐up , 2001, The British journal of dermatology.

[163]  S. Grether-Beck,et al.  Evaluation of the capacity of sunscreens to photoprotect lupus erythematosus patients by employing the photoprovocation test , 2000, Photodermatology, photoimmunology & photomedicine.

[164]  M. Feldmann,et al.  Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials. , 2000, Arthritis and rheumatism.

[165]  S. Walker,et al.  Carbon dioxide laser resurfacing of facial scarring secondary to chronic discoid lupus erythematosus , 2000, The British journal of dermatology.

[166]  T. Ruzicka,et al.  Successful Treatment of Discoid Lupus erythematosus with Argon Laser , 2000, Dermatology.

[167]  G. Roustán,et al.  Lupus erythematosus with an erythema multiforme-like eruption. , 2000, European journal of dermatology : EJD.

[168]  Philip R. Cohen,et al.  Subacute cutaneous lupus erythematosus: report of a patient who subsequently developed a meningioma and whose skin lesions were treated with isotretinoin. , 2000, Cutis.

[169]  R. Sontheimer.  Questions answered and a $1 million question raised concerning lupus erythematosus tumidus: is routine laboratory surveillance testing during treatment with hydroxychloroquine for skin disease really necessary. , 2000, Archives of dermatology.

[170]  A. Pandya,et al.  Pulse intravenous cyclophosphamide therapy for dermatologic disorders. , 2000, Dermatologic clinics.

[171]  D. McCauliffe,et al.  Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment. , 2000, Journal of the American Academy of Dermatology.

[172]  Y. Saeki,et al.  Maintaining remission of lupus erythematosus profundus (LEP) with cyclosporin A , 2000, Lupus.

[173]  L. Rudnicka,et al.  Long-Term Cefuroxime Axetil in Subacute Cutaneous Lupus erythematosus , 2000, Dermatology.

[174]  K. Kyriakis,et al.  Experience with low‐dose thalidomide therapy in chronic discoid lupus erythematosus , 2000, International journal of dermatology.

[175]  C. Specker,et al.  Kombination der Antimalariamittel Mepacrin und Chloroquin bei therapieresistentem kutanem Lupus erythematodes , 2000, Der Hautarzt.

[176]  D. Wallace.  Is there a role for quinacrine (Atabrine) in the new millennium? , 2000, Lupus.

[177]  H. Schuppe,et al.  [Combination of antimalarial drugs mepacrine and chloroquine in therapy refractory cutaneous lupus erythematosus]. , 2000, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[178]  W. Burke,et al.  Treatment of localized discoid lupus erythematosus with tazarotene. , 1999, Journal of the American Academy of Dermatology.

[179]  C. Raulin,et al.  Cutaneous lupus erythematosus—treatment with pulsed dye laser , 1999, The British journal of dermatology.

[180]  O. Chosidow,et al.  High-dose intravenous immunoglobulin in cutaneous lupus erythematosus. , 1999, Archives of dermatology.

[181]  U. Wollina,et al.  Extracoporeal photochemotherapy in cutaneous lupus erythematosus , 1999 .

[182]  L. Vilá,et al.  Association of sunlight exposure and photoprotection measures with clinical outcome in systemic lupus erythematosus. , 1999, Puerto Rico health sciences journal.

[183]  E. Lewis,et al.  Report of an association between discoid lupus erythematosus and smoking. , 1999, Cutis.

[184]  J. Zeldis,et al.  S.T.E.P.S.: a comprehensive program for controlling and monitoring access to thalidomide. , 1999, Clinical therapeutics.

[185]  D. Gladman,et al.  Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus. , 1998, The Journal of rheumatology.

[186]  V. Pistoia,et al.  A case of paediatric discoid lupus erythematosus evolving into SLE. , 1998, Clinical and experimental rheumatology.

[187]  J. Krutmann,et al.  Extrakorporale Photopherese bei therapieresistentem disseminiert diskoidem Lupus erythematodes (DDLE) , 1998, Der Hautarzt.

[188]  I. Böhm,et al.  [ANCA-positive lupus erythematodes profundus. Successful therapy with low dosage dapsone]. , 1998, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[189]  A. Bruns,et al.  ANCA-positiver Lupus erythematodes profundus Erfolgreiche Therapie mit niedrig dosiertem Dapson , 1998, Der Hautarzt.

[190]  J. Jiménez-Alonso,et al.  Antimalarial drug-induced aquagenic-type pruritus in patients with lupus. , 1998, Arthritis and rheumatism.

[191]  R. Schmid,et al.  Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. , 1998, The Journal of clinical investigation.

[192]  H. Chung,et al.  Lupus Panniculitis Treated by a Combination Therapy of Hydroxychloroquine and Quinacrine , 1997, The Journal of dermatology.

[193]  Gerald. D. Levy,et al.  Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice. , 1997, Arthritis and rheumatism.

[194]  P. Puddu,et al.  Intravenous immunoglobulin therapy is not able to efficiently control cutaneous manifestations in patients with lupus erythematosus , 1997, Lupus.

[195]  J. Shupack,et al.  Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses. , 1996, Journal of the American Academy of Dermatology.

[196]  W. Nürnberg,et al.  [Successful treatment of chronic discoid lupus erythematosus with argon laser]. , 1996, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[197]  N. Allı,et al.  EFFICACY OF SULFASALAZINE IN DISCOID LUPUS ERYTHEMATOSUS , 1996, International journal of dermatology.

[198]  H. Mcgrath,et al.  Review : Ultraviolet-A1 (340-400 nm) irradiation therapy in systemic lupus erythematosus , 1996 .

[199]  Guidelines,et al.  Guidelines of care for cutaneous lupus erythematosus , 1996 .

[200]  E. Rieber,et al.  Treatment of severe cutaneous lupus erythematosus with a chimeric CD4 monoclonal antibody, cM-T412. , 1996, Journal of the American Academy of Dermatology.

[201]  R. Sontheimer,et al.  Cutaneous Manifestations of Rheumatic Diseases , 1996 .

[202]  V. Di Lernia,et al.  Discoid lupus erythematosus during treatment with cyclosporine. , 1996, Acta dermato-venereologica.

[203]  Jeffrey R Schein,et al.  Cigarette Smoking and Clinically Significant Drug Interactions , 1995, The Annals of pharmacotherapy.

[204]  W. Bottomley,et al.  Methotrexate for the treatment of discoid lupus erythematosus , 1995, The British journal of dermatology.

[205]  C. Kwoh,et al.  Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year followup study. , 1995, Arthritis and rheumatism.

[206]  C. Elmets,et al.  Photoexacerbation of cutaneous lupus erythematosus due to ultraviolet A emissions from a photocopier. , 1995, Arthritis and rheumatism.

[207]  S. Grabbe,et al.  Coexisting lichen planus and subacute cutaneous lupus erythematosus , 1995, Clinical and experimental dermatology.

[208]  M. Rodríguez-Castellanos,et al.  Phenytoin in the treatment of discoid lupus erythematosus. , 1995, Archives of dermatology.

[209]  J. Arbiser,et al.  Clofazimine: a review of its medical uses and mechanisms of action. , 1995, Journal of the American Academy of Dermatology.

[210]  J. M. Cash,et al.  Treatment of refractory cutaneous lupus erythematosus. , 1995, Rheumatic diseases clinics of North America.

[211]  S. West,et al.  Antihistone antibody profile in sulfasalazine induced lupus. , 1994, The Journal of rheumatology.

[212]  S. Burge,et al.  Cyclosporin and discoid lupus erythematosus , 1994, The British journal of dermatology.

[213]  W. Carey,et al.  Discoid lupus erythematosus: successful treatment with oral methotrexate. , 1994, Archives of dermatology.

[214]  H. Mcgrath.  Ultraviolet-A1 irradiation decreases clinical disease activity and autoantibodies in patients with systemic lupus erythematosus. , 1994, Clinical and experimental rheumatology.

[215]  W. Mccune,et al.  Immunosuppressive drug therapy of systemic lupus erythematosus. , 1994, Rheumatic diseases clinics of North America.

[216]  H. Audring,et al.  [UV-A-1 therapy of subacute cutaneous lupus erythematosus]. , 1993, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[217]  A. Ledo,et al.  Long‐term Results of Intralesional Interferon Alpha‐2B in Discoid Lupus Erythematosus , 1993, The Journal of dermatology.

[218]  W. Cunliffe,et al.  Cutaneous lupus erythematosus. , 1993, Journal of the American Academy of Dermatology.

[219]  N. Esterly,et al.  Antimalarials for children: indications, toxicities, and guidelines. , 1993, Journal of the American Academy of Dermatology.

[220]  P. Duhra.  Treatment of gastrointestinal symptoms associated with methotrexate therapy for psoriasis. , 1993, Journal of the American Academy of Dermatology.

[221]  P. Kind,et al.  Treatment of cutaneous lupus erythematosus with acitretin and hydroxychloroquine , 1992, The British journal of dermatology.

[222]  A. Torrelo,et al.  Low-dose intralesional interferon alfa for discoid lupus erythematosus. , 1992, Journal of the American Academy of Dermatology.

[223]  A. Carmichael,et al.  Discoid lupus erythematosus responsive to sulphasalazine , 1991, The British journal of dermatology.

[224]  S. Goldman,et al.  Cutaneous lupus treated with topical tretinoin: a case report. , 1991, Cutis.

[225]  J. Callen,et al.  Azathioprine. An effective, corticosteroid-sparing therapy for patients with recalcitrant cutaneous lupus erythematosus or with recalcitrant cutaneous leukocytoclastic vasculitis. , 1991, Archives of dermatology.

[226]  Jean Kanitakis,et al.  Response of discoid and subacute cutaneous lupus erythematosus to recombinant interferon alpha 2a. , 1990, The Journal of investigative dermatology.

[227]  B. Furner.  Subacute Cutaneous Lupus Erythematosus, Response to Isotretinoin , 1990, International journal of dermatology.

[228]  J. Callen,et al.  Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency. , 1990, The Journal of rheumatology.

[229]  P. Duhra,et al.  Discoid lupus erythematosus associated with hereditary angioneurotic oedema , 1990, The British journal of dermatology.

[230]  L. Rönnblom,et al.  Possible induction of systemic lupus erythematosus by interferon‐α treatment in a patient with a malignant carcinoid tumour , 1990, Journal of internal medicine.

[231]  Jean Kanitakis,et al.  Recombinant interferon α2a is effective in the treatment of discoid and subacute cutaneous lupus erythematosus , 1990 .

[232]  S. Dekio,et al.  Lupus Erythematosus Profundus , 1989, The Journal of dermatology.

[233]  G. Angelini,et al.  [Use of oral isotretinoin in the treatment of cutaneous lupus erythematosus]. , 1989, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

[234]  D. Wallace.  The use of quinacrine (Atabrine) in rheumatic diseases: a reexamination. , 1989, Seminars in arthritis and rheumatism.

[235]  V. Werth,et al.  Resistant discoid lupus erythematosus of palms and soles: successful treatment with azathioprine. , 1988, Journal of the American Academy of Dermatology.

[236]  G. Hughes,et al.  Danazol and discoid lupus , 1988, The British journal of dermatology.

[237]  T. Bieber,et al.  Efficiency of acitretin in the treatment of cutaneous lupus erythematosus. , 1988, Archives of dermatology.

[238]  Darrell L. Henderson,et al.  Laser treatment of discoid lupus (case report) , 1987, Lasers in surgery and medicine.

[239]  F. Heule,et al.  Cyclosporine in the treatment of lupus erythematosus. , 1986, Archives of dermatology.

[240]  K. Dalziel,et al.  Treatment of chronic discoid lupus erythematosus with an oral gold compound (auranofin) , 1986, The British journal of dermatology.

[241]  R. Stern,et al.  An exacerbation of SLE after visiting a tanning salon. , 1986, JAMA.

[242]  S. Shehade.  Successful treatment of generalized discoid skin lesions with azathioprine. , 1986, Archives of dermatology.

[243]  Jimmy D Bell,et al.  Mechanism-oriented assessment of isotretinoin in chronic or subacute cutaneous lupus erythematosus. , 1986, Archives of dermatology.

[244]  M. Black,et al.  Low‐dose dapsone in the treatment of subacute cutaneous lupus erythematosus , 1986, Clinical and experimental dermatology.

[245]  M. Dougados,et al.  Hormonal modulation in systemic lupus erythematosus. Preliminary clinical and hormonal results with cyproterone acetate. , 1985, Arthritis and rheumatism.

[246]  G. Tsokos,et al.  Successful treatment of generalized discoid skin lesions with azathioprine. Its use in a patient with systemic lupus erythematosus. , 1985, Archives of dermatology.

[247]  O. Braun-falco,et al.  Treatment of cutaneous lupus erythematosus with etretinate. , 1985, Acta dermato-venereologica.

[248]  H. Polet.  The effects of lysosomotropic amines on protein degradation, migration of nonhistone proteins to the nucleus, and cathepsin D in lymphocytes , 1985, Journal of cellular physiology.

[249]  M. Turner,et al.  Annular subacute cutaneous lupus erythematosus responsive to dapsone. , 1984, Journal of the American Academy of Dermatology.

[250]  J. Goldberg,et al.  Pulse methylprednisolone therapy for persistent subacute cutaneous lupus. , 1984, Arthritis and rheumatism.

[251]  R. Happle,et al.  Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosus , 1983, The British journal of dermatology.

[252]  H. Gleichmann.  Systemic lupus erythematosus triggered by diphenlhydantoin , 1982 .

[253]  H. Gleichmann.  Systemic lupus erythematous triggered by diphenylhydantoin. , 1982, Arthritis and rheumatism.

[254]  S. Shuster,et al.  Dapsone and discoid lupus erythematosus , 1982, The British journal of dermatology.

[255]  F. Crovato,et al.  Clofazimine in the treatment of annular lupus erythematosus. , 1981, Archives of dermatology.

[256]  T. Ruzicka,et al.  Dapsone in the treatment of lupus erythematosus , 1981, The British journal of dermatology.

[257]  W. Paver,et al.  Further Study of the Use olf Clolaziinine in Discoid Lupus Erytheniatosus , 1980 .

[258]  Roenigk Hh,et al.  Discoid lupus erythematosus. Diagnostic features and evaluation of topical corticosteroid therapy. , 1980, Cutis.

[259]  E. Dubois.  Antimalarials in the management of discoid and systemic lupus erythematosus. , 1978, Seminars in arthritis and rheumatism.

[260]  J. Bonafé,et al.  [Lamprene (Clofazimine) treatment of chronic lupus erythematoides (author's transl)]. , 1978, Annales de dermatologie et de venereologie.

[261]  G. Cains,et al.  CLOFAZIMINE (LAMPRENE) IN THE TREATMENT OF DISCOID LUPUS ERYTHEMATOSUS , 1976 .

[262]  J. Mackey,et al.  Clofazimine in the treatment of discoid lupus erythematosus , 1974, The British journal of dermatology.

[263]  M. Menter,et al.  TREATMENT OF DISCOID AND SUBACUTE LUPUS ERYTHEMATOSUS WITH CYCLOPHOSPHAMIDE , 1971 .

[264]  Sanford Fb.  The Use of "I". , 1963 .

[265]  F. Page.  Treatment of lupus erythematosus with mepacrine. , 1951, Lancet.

[266]  M. Haust,et al.  Photoprotective effects of a broad-spectrum sunscreen in ultraviolet-induced cutaneous lupus erythematosus: a randomized, vehicle-controlled, double-blind study. , 2011, Journal of the American Academy of Dermatology.

[267]  S. Jessop,et al.  Drugs for discoid lupus erythematosus (Review) , 2009 .

[268]  T. Ruzicka,et al.  Topical calcineurin inhibitors in cutaneous lupus erythematosus , 2008, Archives of Dermatological Research.

[269]  Tzung Ty,et al.  Tacrolimus vs. clobetasol propionate in the treatment of facial cutaneous lupus erythematosus: a randomized, double-blind, bilateral comparison study. , 2007 .

[270]  M. Aringer,et al.  Effects of short-term infliximab therapy on autoantibodies in systemic lupus erythematosus. , 2007, Arthritis and rheumatism.

[271]  T. Luger,et al.  Infliximab-induced lupus erythematosus tumidus in a patient with rheumatoid arthritis. , 2006, Archives of dermatology.

[272]  T. Ruzicka,et al.  Cutaneous lupus erythematosus , 2005 .

[273]  T. Ruzicka,et al.  Dapsone and Retinoids , 2005 .

[274]  P. Lehmann.  Topical Treatment of Cutaneous Lupus Erythematosus , 2005 .

[275]  M. Petri,et al.  High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus. , 2003, Arthritis and rheumatism.

[276]  C. Nousari,et al.  Mycophenolate mofetil for the treatment of cutaneous lupus erythematosus with smoldering systemic involvement. , 2002, Archives of dermatology.

[277]  E. Bartoli,et al.  Cyclosporine-A plus steroids versus steroids alone in the 12-month treatment of systemic lupus erythematosus , 2000, International journal of clinical & laboratory research.

[278]  R. Bauer,et al.  Management of cutaneous lupus erythematosus with low-dose methotrexate: indication for modulation of inflammatory mechanisms , 1998, Rheumatology International.

[279]  A. Amoroso,et al.  Long-term treatment of systemic lupus erythematosus with cyclosporin A. , 1997, Arthritis and rheumatism.

[280]  I. Böhm,et al.  Rapid improvement of subacute cutaneous lupus erythematosus with low-dose methotrexate. , 1997, Dermatology.

[281]  F. Piette,et al.  TRAITEMENT DU LUPUS ERYTHEMATEUX CHRONIQUE PAR LA SULFASALAZINE : 11 OBSERVATIONS , 1994 .

[282]  J. Saurat,et al.  The association of the two antimalarials chloroquine and quinacrine for treatment-resistant chronic and subacute cutaneous lupus erythematosus. , 1994, Dermatology.

[283]  J. A. Johnson,et al.  Broad-spectrum photoprotection: the roles of tinted auto windows, sunscreens and browning agents in the diagnosis and treatment of photosensitivity. , 1992, Dermatology.

[284]  A. Parke,et al.  Isotretinoin for refractory lupus erythematosus. , 1991, Journal of the American Academy of Dermatology.

[285]  B. Steinkjer.  Auranofin in the treatment of discoid lupus erythematosus , 1991 .

[286]  A. Torrelo,et al.  Danazol and discoid lupus erythematosus. , 1990, Dermatologica.

[287]  P. Bjerring,et al.  Argon laser treatment of cutaneous vascular lesions in connective tissue diseases. , 1988, Acta dermato-venereologica.

[288]  A. Steinberg,et al.  NIH conference. Lupus nephritis. , 1987, Annals of internal medicine.

[289]  R. Lindskov,et al.  Dapsone in the treatment of cutaneous lupus erythematosus. , 1986, Dermatologica.

[290]  Kevin A. Johnson,et al.  Inverse Effects of Oxytocin on Attributing Mental Activity to Others in Depressed and Healthy Subjects: A Double-Blind Placebo Controlled fMRI Study , 2010, Front. Psychiatry.